Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients

By afschroeder • October 6, 2026

Olszewski AJ, Eradat HA, Avigdor A, Horowitz NA, McKinney MS, Lee ST, Bergua Burgues JM, Rodriguez Izquierdo A, Bastos-Oreiro M, Ganzel C, Kim TM, Jeon Y, Taszner M, Narkhede MS, Kim WS, Shin HJ, Woszczyk D, Goldschmidt N, Singh A, Wei MC, Wang J, Batlevi CL MD, PhD, Ead W, Janousek M, Sellam G Dr, Jurczak W. Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients. Blood. 2026 Oct 5:blood.2026035116. doi: 10.1182/blood.2026035116. Epub ahead of print. PMID: 42832423.

Tags: Hematology/Oncology, Publications

Rethinking the possibilities of adult ring sideroblastic anaemia

Carlson SG, Koo M, Dommaraju S, Song AH, Chai-Ho W. Rethinking the possibilities of adult ring sideroblastic anaemia. Lancet Haematol. 2026 Oct 6:S2352-3026(26)00133-X. doi: 10.1016/S2352-3026(26)00133-X.[...]

Topoisomerase-Based CDH17 Antibody Drug Conjugates Overcome P-gp Resistance but Undergo Target Mediated Clearance in Colorectal Cancer

O'Brien NA, Zhang J, Gong KW, McDermott MSJ, Hoffstrom B, Lu M, Liang M, Jia WP, Luo T, Madrid AM, Ayala R, Presta L, Larson[...]

Phase 1 dose escalation and expansion trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein SL-172154 (SIRPα-Fc-CD40L) in patients with higher-risk myelodysplastic syndrome or acute myeloid leukemia

Daver NG, Zeidan AM, Stein AS, Zeidner JF, Maher K, Curran E, Bixby D, Chai-Ho W, Stahl M, Yee KWL, Stevens D, Ito S, Reynolds[...]